Business Description
Mycodern SA
ISIN : PLMDNPL00013
Compare
Compare
Traded in other countries / regions
MCD.PolandGY3.Germany IPO Date
2011-12-30Description
Mycodern SA is committed to providing the highest quality functional food and innovative dietary supplement products.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | -0.49 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.07 | |||||
| Beneish M-Score | 4.26 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -60.3 | |||||
| 3-Year Book Growth Rate | 73.4 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 26.84 | |||||
| 14-Day RSI | 27.22 | |||||
| 6-1 Month Momentum % | -10.75 | |||||
| 12-1 Month Momentum % | -54.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.91 | |||||
| Quick Ratio | 0.83 | |||||
| Cash Ratio | 0.01 | |||||
| Days Inventory | 148.14 | |||||
| Days Sales Outstanding | 92.35 | |||||
| Days Payable | 174.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -3.93 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 52.44 | |||||
| Operating Margin % | -8.32 | |||||
| Net Margin % | -75.9 | |||||
| FCF Margin % | -12.99 | |||||
| ROE % | -23.49 | |||||
| ROA % | -16.76 | |||||
| ROIC % | -1.9 | |||||
| 3-Year ROIIC % | -3.24 | |||||
| ROC (Joel Greenblatt) % | -303.22 | |||||
| ROCE % | -20.75 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 9.02 | |||||
| PB Ratio | 3.23 | |||||
| EV-to-EBIT | -12.55 | |||||
| EV-to-EBITDA | -12.95 | |||||
| EV-to-Revenue | 9.27 | |||||
| EV-to-FCF | -71.34 | |||||
| Price-to-Projected-FCF | 4.61 | |||||
| Price-to-Median-PS-Value | 9.22 | |||||
| Earnings Yield (Greenblatt) % | -7.97 | |||||
| FCF Yield % | -1.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mycodern SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil zł) | 6.12 | ||
| EPS (TTM) (zł) | -0.069 | ||
| Beta | -1.05 | ||
| Volatility % | 53.98 | ||
| 14-Day RSI | 27.22 | ||
| 14-Day ATR (zł) | 0.000007 | ||
| 20-Day SMA (zł) | 0.83 | ||
| 12-1 Month Momentum % | -54.64 | ||
| 52-Week Range (zł) | 0.78 - 1.85 | ||
| Shares Outstanding (Mil) | 65.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mycodern SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mycodern SA Stock Events
| Event | Date | Price(zł) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mycodern SA Frequently Asked Questions
What is Mycodern SA(WAR:MCD)'s stock price today?
The current price of WAR:MCD is zł0.83. The 52 week high of WAR:MCD is zł1.85 and 52 week low is zł0.78.
When is next earnings date of Mycodern SA(WAR:MCD)?
The next earnings date of Mycodern SA(WAR:MCD) is .
Does Mycodern SA(WAR:MCD) pay dividends? If so, how much?
Mycodern SA(WAR:MCD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers